Company news
Sharp Therapeutics Corp. (TSXV:SHRX) news
Sharp Therapeutics Corp. news releases on 6ix. Latest, Aug 28, 2026: Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
Press releases & updates
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
Sharp Therapeutics Announces Closing of Non-Brokered Private Placement
July 29, 2026
Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
July 15, 2026
Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date
June 30, 2026
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
May 28, 2026
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 17, 2026
Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs
April 10, 2026
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
April 10, 2026
Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering
April 2, 2026
Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering
March 13, 2026
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
February 27, 2026
Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes
February 2, 2026
Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board
January 27, 2026
Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options
December 19, 2025
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
Canadian Investment Regulatory Organization Trade Resumption - SHRX
October 14, 2025
Canadian Investment Regulatory Organization Trading Halt - SHRX
October 14, 2025
Sharp Therapeutics Arranges Non-Brokered Private Placement
October 14, 2025
Sharp Therapeutics to Present Pipeline and Program Updates at World Orphan Drug Congress 2025
October 8, 2025
Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB
August 29, 2025
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 29, 2025
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 21, 2025
Sharp Therapeutics Corp. Reports First Quarter 2025 Results
May 22, 2025
Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher's Disease
May 13, 2025
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
Sharp Therapeutics Corp. Announces Share Consolidation
January 16, 2025
Sharp Therapeutics Corp. Announces Completion of Qualifying Transaction
December 12, 2024